Search clinical trials for: 68Ga-Pentixafor PET/CT

Total 1543 results

First Affiliated Hospital of Fujian Medical University

Recruiting

Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE

Positron-Emission Tomography

China
Qifu Li
Xiangya Hospital of Central South University; West China Hospital; Tongji Hospital and other collaborators

Recruiting

Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism (GAPA)

Primary Aldosteronism

China
Zhongnan Hospital

Recruiting

CXCR4-targeted PET/CT Imaging in Hematological Malignancies

Hematological Malignancy | CXCR4 | PET/CT

China
Qifu Li
The Affiliated Hospital Of Southwest Medical University

Completed

68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism

Primary Aldosteronism

China
Yusuf Menda
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Active, not recruiting

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Peking Union Medical College Hospital

Recruiting

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Multiple Myeloma

China
John O. Prior

Recruiting

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

Cardiac Sarcoidosis | Acute Cellular Graft Rejection | Myocarditis Due to Drug

Switzerland
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-Pentixafor PET/CT for Thymoma

Thymoma

China
PentixaPharm GmbH

Terminated

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

CNS Lymphoma

Denmark, France
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
Nantes University Hospital

Withdrawn

Relevance Evaluation of [68Ga]Ga-PentixaFor for Initial Staging and Detection of Minimal Residual Disease in Multiple Myeloma Patients. (PENTI-MIDAS)

Multiple Myeloma

France
Memorial Sloan Kettering Cancer Center
Pentixapharm AG

Recruiting

In-Human CXCR4 Imaging of Blood Cancers Using [68Ga]-Pentixafor-PET

Multiple Myeloma | Non-Hodgkin Lymphoma | Erdheim-Chester Disease | Rosai-Dorfman Disease | Histiocytic Neoplasms

United States
Peking Union Medical College Hospital

Unknown

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

Lymphoma | Multiple Myeloma

China
First Affiliated Hospital of Fujian Medical University

Recruiting

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Lymphoma | Leukemia | Multiple Myeloma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

China
Nantes University Hospital

Recruiting

Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma in First Line Treatment (PentiMyelo)

Multiple Myeloma

France
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Jonsson Comprehensive Cancer Center

Completed

Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients

Neuroendocrine Carcinoma

United States
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

Primary Myelofibrosis

China
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction (DOLPHIN)

Atheroscleroses, Coronary

Netherlands
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
Mayo Clinic

Active, not recruiting

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

Osteomalacia

United States
The First Affiliated Hospital of Xiamen University

Recruiting

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

Ovarian Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Targeting Molecular Imaging of Solid Tumors

Gastrointestinal Tumors

China
Jewish General Hospital

Completed

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Neuroendocrine Tumors

Canada
Assistance Publique Hopitaux De Marseille

Completed

[68 Ga]-DOTANOC PET/CT in GEP-NETs (GEP-NOC)

Gastroenteropancreatic Neuroendocrine Tumors

France
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
Assistance Publique - Hôpitaux de Paris
Pentixapharm AG

Not yet recruiting

Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism (PENTALON)

Primary Aldosteronism

France
University of Alabama at Birmingham

Completed

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

Metastatic Prostate Cancer

United States
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

Pancreatic Cancer

China
Rigshospitalet, Denmark

Recruiting

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma | Large Cell Neuroendocrine Carcinoma of the Lung

Denmark
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Terminated

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Italy
Cancer Institute and Hospital, Chinese Academy...
Peking University; Peking University Cancer Hospital & Institute

Recruiting

68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer

Malignant Tumor | Positron Emission Tomography | Fibroblast Activation Protein Inhibitor

China
Peking Union Medical College Hospital

Active, not recruiting

Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)

Breast Cancer

China
Radboud University Medical Center

Terminated

Visualizing Beta Cells After Islet Transplantation (GLP1-transpl)

Type 1 Diabetes Mellitus

Netherlands, Sweden
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Terminated

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
First Affiliated Hospital of Fujian Medical University

Unknown

68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer

Metastasis | Tumor | Positron-Emission Tomography

China
First Affiliated Hospital of Fujian Medical University

Recruiting

[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors

Bone Metastases | Bone Tumor

China
Peter MacCallum Cancer Centre, Australia

Recruiting

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions (SPECIFIC)

Invasive Fungal Infections

Australia
Radboud University Medical Center
Rijnstate Hospital

Recruiting

Visualizing Beta Cells After Bariatric Surgery (GLP1-bar)

Type 2 Diabetes Mellitus

Netherlands
Alberta Health services

Recruiting

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Neuroendocrine Tumors (NET)

Canada
The First Affiliated Hospital of Xiamen University

Recruiting

PET Imaging of LAG-3 Expression

Tumor, Solid

China
Jonsson Comprehensive Cancer Center

No longer available

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Neuroendocrine Tumors | Medullary Thyroid Cancer | Carcinoid Cancer | Cancers Expressing Somatostatin Receptors

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Von Hippel-Lindau Disease

Von Hippel-Lindau Disease

China
Guangdong Provincial People's Hospital
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Recruiting

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors (68Ga-GPFAPI)

Cancer | Metastatic Cancer | Malignant Neoplasm | Tumors

China
Peking University Cancer Hospital & Institute

Recruiting

Research for the Molecular Imaging of the HER2 Targeting Tracer

HER2 Positive or Suspicious Positive Tumors

China
Peking Union Medical College Hospital

Unknown

68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis

Pulmonary Fibrosis, Unspecified

China
Peking Union Medical College Hospital

Active, not recruiting

FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

Hepatocellular Carcinoma | Bile Duct Cancer

China

Search clinical trials for: 68Ga-Pentixafor PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations